Growth Metrics

Re (RMAX) Research & Development (2024 - 2025)

Re (RMAX) has disclosed Research & Development for 2 consecutive years, with -$8.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Research & Development fell 268.23% to -$8.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.5 million, a 83.44% decrease, with the full-year FY2025 number at $2.5 million, down 83.44% from a year prior.
  • Research & Development was -$8.0 million for Q4 2025 at Re, down from $8.9 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $8.9 million in Q3 2025 to a low of -$8.0 million in Q4 2025.